Felix Niggli

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi et al. · Blood · 2010 · 778 citations · Full text

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 601 citations · Full text

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Anja Möricke, M Zimmermann, Alfred Reiter et al. · Leukemia · 2009 · 520 citations

Hematological Malignancy, Lymphoid Neoplasia, All-bfm Study Group +9

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

T Flohr, André Schrauder, Giovanni Cazzaniga et al. · Leukemia · 2008 · 357 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence

Birgit Burkhardt, Martin Zimmermann, Ilske Oschlies et al. · British Journal of Haematology · 2005 · 333 citations

Treatment Outcome, Pathology, Clinical Features +16